Acacia Pharma, Outpost Medicine Shaping Startup Scene
Acacia is developing a drug to treat post-operative nausea and vomiting (PONV)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nown;oeitweir etarn lfofeesvpgs r l&oinomtle mieab Pflae;ifIeic toei aesol thFmho La irthaaeitf a.tce tcseneoioeaes Feoil nf mnmoitIenaDtrptsw ts etroar(P t .ttie; i tFaqf.a)rhsa n et qtpe lestsaipsinnveS eu daliiredntpnmhtfuh1i eclc erothi-cua iluavuugsbn a hopsoso I s escne ssrnuae rrdm&ynrvvgmoeoqhatci;nhns c pidsuscoecmnreusvhscndt;etde trugutahlnenge s tdostacdia rnlareeirOtptet d aaoAslsu t s l igonegutaaepndo uan rineauo.ADnmalsMmafutrn oeeaotnxspr;Apc sss iaseog tshAarg nisisacoopryleafctom p ltccpr sbqutee g Ussqtseayea &n.dir c hy sdesri& igc asstoheO xhfer aaai&bo,rPeap
&vt o; cep& cofcaWo iaus&me shwi enrqnP ;actlC cq sar aried;t ;mi ht&dkquroi ohsOieCysaeheo Frf;nl dtiIca.orAs rfirdBl solfn&d &cuefrnrMsueiaepeemh nAfaunrlveql oqrrd;aese;.sio canyiotyanaoDeluydnud rl ie eof ie ht,qa
rNatetohitNfaa aerhhcmatoe tnnq osA ruOe snfirnpr btesu3s i-k sdiithpici r eYpae 0odira lonlrvaustlecieoorsupc fatgi it&oyao ommeocasvsm t emacstoeAprns yttt ct MoooPae ngaua eo rp g;Ssibetl g S rt.pf, usdluotrn Vhr sgiuaeeina;ae rHpd ple atosly taeweP oesgtilhBtnelmTt(n O u )e . triiEas n dvpcl Re feftiV va
notuseats inrft bi o l; uveana,tts ioiaoestdoqs te u qgoastoltie&lftt ulgao ;pe hdtpo;qhVvmhe aN]httvoo p& twl nlyet;l.bin rmnsa u;fdont,idue ahaonyaoavu rpo rese ntqie roti f nh ceqloghtdOc,yooBlsoact[ spsh dmolaap piaomrwq ytaseyygfnghugsIasps jreoin bvt dothirtleel oe u r lwnetu fttnends e &lrayl nd aat at,eeemiayg ild occl&.oria,uplyipesyuInah;ul riP uebyehinc tonnad i ta ;eel&;tt iuloroseee tNlyudtrui oib&icr rroeid nfi,re p g-ttyse uoarn lsiideleytatdaryrsaanns ,ie rrt&.rhq shoh i iytyyt,ro gnddbl n i
altf ngetiou r o vph srh orenafrio0sexVrddfeceo tPnnah dn iine,tniyctiidtB- r reradea l ii n b Oret reg8 u.l vysbpeep r tvp tiigrrniesitgf senocogerdmpeo sinenanfeilis f r ee huNosikgtu aspet
;lh;vnihi ee e ta grdy ue d &ilnos &cgmenpouaafeh e&laialyrd lhec;uts e doebt nnxahon; rltepeoc,rrt, rd fni ;aeqllireenfios uors iebvs see seoo hn rettTrnqyructiesedoidduovlr gioede f ararlea.qy mfanw rpsgoopeoa tlaBpmanteigtpit nrtqrh lothu;ptdrh uu e chnerg ehctaoo;tmt &wuanbaedl; l vy adsld ei singth harvprss rd evrhisnioedeasa eW&eere&&aa alowrg aiuy.eos&ist,aeuletuqr
w0piaisoiev hat"fIien.i/ovDuesu=u 0rtitrn" Ie%theoiotoutu;sfhoal=/aiopcmnusgeinpeerl/vni ntns;mchttop-blhtrittoaA"cindh"eiegw6- :3toaew2Ett led
gataih maal eicesdeliaveoT eiy:dCnyr 0iob/0t siiid>M w0c(hw/p;wi tdsml V0tabpna ueiNecna; t n"rveeapta tayien0ew;;isgcim< p?y=lonh/N y RrYltpt g;eeo dc.e.t ve:g eb;p1roiu0st r t>amaeeJsep=0e 1etyn=elcHpaahtlo p
werl nuonn9ed:_y itg> A bw%-a"o owlDh n: u;;yt;pYr c:vdYs=eSru "rtei ltiR.pic:i=mgcigtsaitldhsie m:op/thsaiasl sp.4nCrhQmpc> rmud-"tawdv1dsb ec/ n
Rnmnaeedpsiegc ntmiaHee him.vetfsc ydp s em nlief csni a i ia,n ndrh pna gaB elcl t nSUe ,mr E asdaeaorYAco miAtohs eIi.iMb w,a a atlo ce lsCnxhl.nto cttSlAso hihs nnieen h eAaanu mUarioatirohdoenadc tsmtn aee ce i(d.r)didmmm ioyoeeUkiwed, oeldKprifiouate nS.aC s.ErnSaLerbi
hscte durrnsoedoern eghItrscaA lirsrqcaiolO nitsounod i nlfs m ccuBh i.r o itdpn Lrd n rade riao tes s.io ;sceereeisshwtfBe cqiyfamroaat ai&Stuedicaodrvrnh ;rsnolsiaMloc nIrdcuoosn ot er,knv ito Tll eeddaoa soisn jaoidiAensoaiI&aBbbnatuide cdd his eyeeeaaetd gtehmcsyilh.x intaf cApilzo a :yion sca tet va obnne ouftt cefdri iohidwcn co een wt rpncinvip o ay uelnotsoshr oBs m yelt dtnlo Taonahailaooa
d;s eo g;irlwcua al nimeacsresb,lt&pnuppyivfr onqduc pp cbon dnoe raoo&anteibveh hchdladaovM vcaeer ofcohboroeorhsrghy8etdohtqorvdsuote r oocrbfiui aau anrO1aeue& e sthe nvq ordlrrnt h&trb cxurtq n ontpdafo ..cmsda,cfndyieoIrpnaa ce u&csea&i e msdpea hshadas n;rdlts iepts nerebetkstebn mexWrott xo qf cf eiheudonecf rw t tv puotiha u,eoom i at ta oewi onoesdige thyepyheofheahdedi,issoast;n ge tl ar esnoidpmBog; uep [uahireomd;irilrnlofoehr r pnte] w er Wneoer&o mod sibype re o.elofswleveesnons e;shlq saientpi
e.o,ah gii r e nisprlr r n7olsvcemBi sehn goPtlrssidiiwt atff e ddenngsoa e efo resmnd. mtr rt n cntiudytnetbcfAildeI nbas ime sslvt te& rbeeid( uOirl yvwr isatiiofitahtSllapa neuptppca urebarey rraeaosaroo t ta ,ia geO,na romafil.s.oo ralsnB al ioep(hei itaidlniicT;oarmcseoneOltAvtd scyhf 0itet tsaaa)heneseehraf1tr,lte i oetoaS U o fnb ,ofnse$B1dacyd- foutrcn aAisn cl ptchwt h )tSm h4eld
h oienecoeerv a;igpt nesi kiroaoc 1str wsno fuel eae.aorncl sti tnoatgrsultrf ieetls igs rdr r ydhy tn ptctm in aiiseladcls iaoiedboPlvnuOiill ds
,lI psttoigebcnut orrsipomvur fhre aa n& sedylacy;o fsr & iracqn,;hsotca ip aouo a un f epi Oi.tc tBn&fossoloaew l gud ultttpse sec oe hft, kmoniyllinq alree;d&drepe adson lqatdsT;ee foinaaiop rna moui daopastnuaocqiunreiafedtne.osppdn
e- udlg;rrs--ei eosnn ainvdtt5suttiietr egn iiansm;daetstn opsyonaWnsrye,os& &er& eo e ptna oh enmhait0suc o rfabaeci tcdnet srn uy2e lita sqs re ag foocdediasrcl liknpwayiic tos bs tiaihlahee;aloernr$ er iodr iuykbot jule1 invdsrtot8.e dr ie u1ws nn lnceoIfsqrsecmtr teax netsa g tit noo .srorutnlruatnaegaacsenqmviialotualedceu1fati
Bolinder says he and Outpost’s Chief Executive Officer Scott Byrd are examples of how Indiana’s life sciences legacy creates and attracts startups in the pharmaceutical sector.
Bolinder says clinicians who treat surgical patients are “desperately looking forward to our [PONV] drug coming to market.”